Cargando…

Poisoning of Butanol-Containing Products: Clinical Characteristics and Outcomes

BACKGROUND: Butanol (butyl alcohol) is a chemical which occurs naturally in some foods and is used in the manufacture of other chemicals. Current data on butanol poisoning in humans are limited. OBJECTIVE: This study describes clinical characteristics and outcomes of patients exposed to products con...

Descripción completa

Detalles Bibliográficos
Autores principales: Trakulsrichai, Satariya, Boonyok, Nitchakarn, Tansuwannarat, Phantakan, Sriapha, Charuwan, Wananukul, Winai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473844/
https://www.ncbi.nlm.nih.gov/pubmed/34588804
http://dx.doi.org/10.2147/IJGM.S325398
_version_ 1784575084370853888
author Trakulsrichai, Satariya
Boonyok, Nitchakarn
Tansuwannarat, Phantakan
Sriapha, Charuwan
Wananukul, Winai
author_facet Trakulsrichai, Satariya
Boonyok, Nitchakarn
Tansuwannarat, Phantakan
Sriapha, Charuwan
Wananukul, Winai
author_sort Trakulsrichai, Satariya
collection PubMed
description BACKGROUND: Butanol (butyl alcohol) is a chemical which occurs naturally in some foods and is used in the manufacture of other chemicals. Current data on butanol poisoning in humans are limited. OBJECTIVE: This study describes clinical characteristics and outcomes of patients exposed to products containing butanol. METHODS: We performed a 5-year retrospective cross-sectional study by analyzing data from the Ramathibodi Poison Center Toxic Exposure Surveillance System for 2013–2017. RESULTS: There were 163 patients included in the study. All products containing butanol reported were agricultural adjuvant products. Most (67.5%) patients were males and had ingested butanol accidentally (75.5%). The median age was 42 years. Almost all patients had oral exposure to butanol. At presentation, most of our patients had normal vital signs and were conscious. Clinical presentations mostly included gastrointestinal symptoms (65%) and local irritation (28.8%). Fifty-four patients (33.1%) had no obvious clinical effects at presentation. Most patients had normal laboratory tests at presentation, although eight developed systemic effects including high anion gap metabolic acidosis (n=8), acute kidney injury (AKI; n=5), depression of consciousness (n=5), and hypotension (n=3). Of these eight patients, two with intentional ingestion developed altered consciousness, hypotension, AKI, severe metabolic acidosis, and eventually died. One of these died within 1 day after ingestion, while the other died later through complications during admission. Therefore, the mortality rate was 1.23%. Sixty-six patients (40.5%) were admitted to hospitals, with a median length of stay of 1 day. Most patients received only supportive treatment and fully recovered. CONCLUSION: Agricultural adjuvant products containing butanol or butanol itself caused only mild effects in most patients, but systemic effects occurred in some. The mortality from this poisoning was very low, and both fatalities were from intentional ingestion. Supportive care and proper management of complications should be the main treatment for this form of poisoning.
format Online
Article
Text
id pubmed-8473844
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84738442021-09-28 Poisoning of Butanol-Containing Products: Clinical Characteristics and Outcomes Trakulsrichai, Satariya Boonyok, Nitchakarn Tansuwannarat, Phantakan Sriapha, Charuwan Wananukul, Winai Int J Gen Med Original Research BACKGROUND: Butanol (butyl alcohol) is a chemical which occurs naturally in some foods and is used in the manufacture of other chemicals. Current data on butanol poisoning in humans are limited. OBJECTIVE: This study describes clinical characteristics and outcomes of patients exposed to products containing butanol. METHODS: We performed a 5-year retrospective cross-sectional study by analyzing data from the Ramathibodi Poison Center Toxic Exposure Surveillance System for 2013–2017. RESULTS: There were 163 patients included in the study. All products containing butanol reported were agricultural adjuvant products. Most (67.5%) patients were males and had ingested butanol accidentally (75.5%). The median age was 42 years. Almost all patients had oral exposure to butanol. At presentation, most of our patients had normal vital signs and were conscious. Clinical presentations mostly included gastrointestinal symptoms (65%) and local irritation (28.8%). Fifty-four patients (33.1%) had no obvious clinical effects at presentation. Most patients had normal laboratory tests at presentation, although eight developed systemic effects including high anion gap metabolic acidosis (n=8), acute kidney injury (AKI; n=5), depression of consciousness (n=5), and hypotension (n=3). Of these eight patients, two with intentional ingestion developed altered consciousness, hypotension, AKI, severe metabolic acidosis, and eventually died. One of these died within 1 day after ingestion, while the other died later through complications during admission. Therefore, the mortality rate was 1.23%. Sixty-six patients (40.5%) were admitted to hospitals, with a median length of stay of 1 day. Most patients received only supportive treatment and fully recovered. CONCLUSION: Agricultural adjuvant products containing butanol or butanol itself caused only mild effects in most patients, but systemic effects occurred in some. The mortality from this poisoning was very low, and both fatalities were from intentional ingestion. Supportive care and proper management of complications should be the main treatment for this form of poisoning. Dove 2021-09-22 /pmc/articles/PMC8473844/ /pubmed/34588804 http://dx.doi.org/10.2147/IJGM.S325398 Text en © 2021 Trakulsrichai et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Trakulsrichai, Satariya
Boonyok, Nitchakarn
Tansuwannarat, Phantakan
Sriapha, Charuwan
Wananukul, Winai
Poisoning of Butanol-Containing Products: Clinical Characteristics and Outcomes
title Poisoning of Butanol-Containing Products: Clinical Characteristics and Outcomes
title_full Poisoning of Butanol-Containing Products: Clinical Characteristics and Outcomes
title_fullStr Poisoning of Butanol-Containing Products: Clinical Characteristics and Outcomes
title_full_unstemmed Poisoning of Butanol-Containing Products: Clinical Characteristics and Outcomes
title_short Poisoning of Butanol-Containing Products: Clinical Characteristics and Outcomes
title_sort poisoning of butanol-containing products: clinical characteristics and outcomes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473844/
https://www.ncbi.nlm.nih.gov/pubmed/34588804
http://dx.doi.org/10.2147/IJGM.S325398
work_keys_str_mv AT trakulsrichaisatariya poisoningofbutanolcontainingproductsclinicalcharacteristicsandoutcomes
AT boonyoknitchakarn poisoningofbutanolcontainingproductsclinicalcharacteristicsandoutcomes
AT tansuwannaratphantakan poisoningofbutanolcontainingproductsclinicalcharacteristicsandoutcomes
AT sriaphacharuwan poisoningofbutanolcontainingproductsclinicalcharacteristicsandoutcomes
AT wananukulwinai poisoningofbutanolcontainingproductsclinicalcharacteristicsandoutcomes